108 related articles for article (PubMed ID: 25091816)
61. CRTAM Protects Against Intestinal Dysbiosis During Pathogenic Parasitic Infection by Enabling Th17 Maturation.
Cervantes-Barragan L; Cortez VS; Wang Q; McDonald KG; Chai JN; Di Luccia B; Gilfillan S; Hsieh CS; Newberry RD; Sibley LD; Colonna M
Front Immunol; 2019; 10():1423. PubMed ID: 31312200
[TBL] [Abstract][Full Text] [Related]
62. Dermal mast cells reduce progressive tissue necrosis caused by subcutaneous infection with Streptococcus pyogenes in mice.
Matsui H; Sekiya Y; Takahashi T; Nakamura M; Imanishi K; Yoshida H; Murayama SY; Takahashi T; Tsuchimoto K; Uchiyama T; Ubukata K
J Med Microbiol; 2011 Jan; 60(Pt 1):128-134. PubMed ID: 20884771
[TBL] [Abstract][Full Text] [Related]
63. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection.
Kelly MN; Kolls JK; Happel K; Schwartzman JD; Schwarzenberger P; Combe C; Moretto M; Khan IA
Infect Immun; 2005 Jan; 73(1):617-21. PubMed ID: 15618203
[TBL] [Abstract][Full Text] [Related]
64. Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL-37.
Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Theoharides TC
Eur J Pharmacol; 2018 Jan; 818():294-299. PubMed ID: 28970014
[TBL] [Abstract][Full Text] [Related]
65. Unimpaired Responses to Vaccination With Protein Antigen Plus Adjuvant in Mice With Kit-Independent Mast Cell Deficiency.
Schubert N; Lisenko K; Auerbach C; Weitzmann A; Ghouse SM; Muhandes L; Haase C; Häring T; Schulze L; Voehringer D; Gunzer F; Müller W; Feyerabend TB; Rodewald HR; Dudeck A; Roers A
Front Immunol; 2018; 9():1870. PubMed ID: 30210490
[TBL] [Abstract][Full Text] [Related]
66. Impact of MyD88, Microbiota, and Location on Type 1 and Type 3 Innate Lymphoid Cells during
Snyder LM; Belmares-Ortega J; Doherty CM; Denkers EY
Immunohorizons; 2022 Sep; 6(9):660-670. PubMed ID: 36096673
[No Abstract] [Full Text] [Related]
67. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses.
Hand TW; Dos Santos LM; Bouladoux N; Molloy MJ; Pagán AJ; Pepper M; Maynard CL; Elson CO; Belkaid Y
Science; 2012 Sep; 337(6101):1553-6. PubMed ID: 22923434
[TBL] [Abstract][Full Text] [Related]
68. The Roles of Mast Cells in Parasitic Protozoan Infections.
Lu F; Huang S
Front Immunol; 2017; 8():363. PubMed ID: 28428784
[TBL] [Abstract][Full Text] [Related]
69. Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondii.
Berrocal Almanza LC; Muñoz M; Kühl AA; Kamradt T; Heimesaat MM; Liesenfeld O
Eur J Microbiol Immunol (Bp); 2013 Sep; 3(3):211-21. PubMed ID: 24265941
[TBL] [Abstract][Full Text] [Related]
70. Securing mucosal borders--migrant monocytes to the rescue.
Yap GS; Iwasaki A
Cell Host Microbe; 2008 Sep; 4(3):192-4. PubMed ID: 18779043
[TBL] [Abstract][Full Text] [Related]
71. The Role of Mast Cells in Bacterial Infection.
Johnzon CF; Rönnberg E; Pejler G
Am J Pathol; 2016 Jan; 186(1):4-14. PubMed ID: 26477818
[TBL] [Abstract][Full Text] [Related]
72. Immunogenetics influence outcome of Toxoplasma gondii infection.
McLeod R; Brown C; Mack D
Res Immunol; 1993 Jan; 144(1):61-5. PubMed ID: 8451521
[No Abstract] [Full Text] [Related]
73. Antitumor effects of a Toxoplasma mutant lacking lactate dehydrogenases.
Li Y; Zhang Y; Xia N; Zhou T; Shen B
Parasitol Res; 2021 Sep; 120(9):3335-3339. PubMed ID: 34405281
[TBL] [Abstract][Full Text] [Related]
74. Potential effector and immunoregulatory functions of mast cells in mucosal immunity.
Reber LL; Sibilano R; Mukai K; Galli SJ
Mucosal Immunol; 2015 May; 8(3):444-63. PubMed ID: 25669149
[TBL] [Abstract][Full Text] [Related]
75. Internalization and TLR-dependent type I interferon production by monocytes in response to Toxoplasma gondii.
Han SJ; Melichar HJ; Coombes JL; Chan SW; Koshy AA; Boothroyd JC; Barton GM; Robey EA
Immunol Cell Biol; 2014 Nov; 92(10):872-81. PubMed ID: 25155465
[TBL] [Abstract][Full Text] [Related]
76. Ancient origin of mast cells.
Wong GW; Zhuo L; Kimata K; Lam BK; Satoh N; Stevens RL
Biochem Biophys Res Commun; 2014 Aug; 451(2):314-8. PubMed ID: 25094046
[TBL] [Abstract][Full Text] [Related]
77. Activation of Mast Cells Promote
Huang B; Huang S; Chen X; Liu XB; Wu Q; Wang Y; Li X; Li K; Gao H; Cen S; Lin R; Liu Z; Jin X
Front Cell Infect Microbiol; 2019; 9():322. PubMed ID: 31552201
[TBL] [Abstract][Full Text] [Related]
78. Virulence of atypical Toxoplasma gondii strains isolated in French Guiana in a murine model.
Simon S; de Thoisy B; Mercier A; Nacher M; Demar M
Parasite; 2019; 26():60. PubMed ID: 31549631
[TBL] [Abstract][Full Text] [Related]
79. Production of Inflammatory Cytokines and Nitric Oxide by Human Mast Cells Incubated with Toxoplasma gondii Lysate.
Park EA; Han IH; Kim JH; Park SJ; Ryu JS; Ahn MH
Korean J Parasitol; 2019 Apr; 57(2):201-206. PubMed ID: 31104415
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
